Wells Fargo & Company MN raised its position in shares of Shockwave Medical Inc (NASDAQ:SWAV) by 20.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 110,310 shares of the company’s stock after purchasing an additional 18,890 shares during the quarter. Wells Fargo & Company MN’s holdings in Shockwave Medical were worth $6,298,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in SWAV. Advisory Services Network LLC acquired a new stake in Shockwave Medical during the first quarter valued at approximately $26,000. Advisor Group Inc. acquired a new stake in Shockwave Medical during the second quarter valued at approximately $56,000. Strs Ohio acquired a new stake in shares of Shockwave Medical during the 2nd quarter worth approximately $102,000. Stephens Inc. AR acquired a new stake in shares of Shockwave Medical during the 1st quarter worth approximately $382,000. Finally, Janney Montgomery Scott LLC acquired a new stake in shares of Shockwave Medical during the 2nd quarter worth approximately $422,000. Hedge funds and other institutional investors own 47.96% of the company’s stock.

In related news, CFO Dan Puckett sold 75,000 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $34.71, for a total value of $2,603,250.00. Also, Director Antoine Papiernik sold 650,000 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $34.35, for a total value of $22,327,500.00.

A number of brokerages have recently weighed in on SWAV. Zacks Investment Research cut Shockwave Medical from a “hold” rating to a “sell” rating in a research report on Tuesday, July 9th. Canaccord Genuity increased their price target on Shockwave Medical from $50.00 to $65.00 and gave the stock a “positive” rating in a research report on Tuesday, June 18th. Finally, Bank of America reiterated a “neutral” rating and set a $44.00 price target on shares of Shockwave Medical in a research report on Thursday, June 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $43.50.

Shares of Shockwave Medical stock traded up $0.51 on Monday, reaching $31.18. 106,566 shares of the company were exchanged, compared to its average volume of 594,579. The company has a current ratio of 9.13, a quick ratio of 8.59 and a debt-to-equity ratio of 0.10. The stock has a 50-day moving average price of $41.96. Shockwave Medical Inc has a 1-year low of $24.58 and a 1-year high of $68.39.

Shockwave Medical (NASDAQ:SWAV) last announced its quarterly earnings results on Monday, August 5th. The company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.17. The company had revenue of $10.00 million for the quarter, compared to analyst estimates of $8.29 million. The company’s revenue for the quarter was up 334.8% on a year-over-year basis. Sell-side analysts predict that Shockwave Medical Inc will post -2.51 earnings per share for the current year.

Shockwave Medical Company Profile

ShockWave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease.

Read More: What is meant by buying and selling pressure?

Want to see what other hedge funds are holding SWAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shockwave Medical Inc (NASDAQ:SWAV).

Institutional Ownership by Quarter for Shockwave Medical (NASDAQ:SWAV)

Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.